We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
76 hedge funds and large institutions have $49.8M invested in Lineage Cell Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,600% more call options, than puts
Call options by funds: $67K | Put options by funds: $1K
3% more capital invested
Capital invested by funds: $48.5M → $49.8M (+$1.37M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1.45% less ownership
Funds ownership: 37.18% → 35.73% (-1.4%)
19% less funds holding
Funds holding: 94 → 76 (-18)
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
90% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 20
Holders
76
Holders Change
-18
Holders Change %
-19.15%
% of All Funds
1.53%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
2
Increased
13
Reduced
24
Closed
20
Calls
$67K
Puts
$1K
Net Calls
+$66K
Net Calls Change
-$30K
Top Buyers
| 1 |
DC
Defender Capital
Charlotte,
North Carolina
|
+$356K |
| 2 |
Millennium Management
New York
|
+$303K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$112K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$81.1K |
| 5 |
Two Sigma Advisers
New York
|
+$40.5K |
Top Sellers
| 1 |
Jane Street
New York
|
-$718K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$665K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$284K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$219K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$136K |
